Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2003
03/20/2003WO2002099075A3 Prmts as modifiers of the p53 pathway and methods of use
03/20/2003WO2002099067A3 Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
03/20/2003WO2002098913A3 Polypeptides and corresponding polynucleotides for prophylaxis and treatment of colon cancer
03/20/2003WO2002096364A3 Feline bronchioloalveolar lung carcinoma xenograft and cell line
03/20/2003WO2002095021A8 A repressor-mediated regulation system for control of gene expression in plants
03/20/2003WO2002092131A3 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
03/20/2003WO2002090545A9 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide
03/20/2003WO2002090494A3 Isolation, characterization, cloning and use of a mushroom lectin
03/20/2003WO2002090379A8 Process for inactivating prions in lipoproteins
03/20/2003WO2002087509A3 Colloidal metal compositions and methods
03/20/2003WO2002086076A3 Polynucleotides and polypeptides associated with the nf-kb pathway
03/20/2003WO2002081500A3 Methods for enhancing a plant stress response
03/20/2003WO2002079449A3 Molecules for disease detection and treatment
03/20/2003WO2002079404A3 Cytoskeleton-associated proteins
03/20/2003WO2002078614A3 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof
03/20/2003WO2002078438A3 Tissue-preferred promoter from maize
03/20/2003WO2002077290A9 Methods for modifying pharmacokinetics and bioavailability of exogenous compounds
03/20/2003WO2002074045A3 Production of pancreatic islet cells and delivery of insulin
03/20/2003WO2002072846A9 Synthetic genes and bacterial plasmids devoid of cpg
03/20/2003WO2002072602A3 Somatostatin antagonists
03/20/2003WO2002072024A3 Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto
03/20/2003WO2002070554A3 Dna encoding human cid2
03/20/2003WO2002060934A3 IDENTIFICATION OF THE ANTI-σ28 FACTOR IN HELICOBACTER PYLORI, IN CAMPYLOBACTER JEJUNI AND IN PSEUDOMONAS AERUGINOSA AND APPLICATION THEREOF
03/20/2003WO2002060317A3 Compositions and methods for the therapy and diagnosis of pancreatic cancer
03/20/2003WO2002053760A3 Chimeric cytolytic viruses for cancer treatment
03/20/2003WO2002053733A3 Regulation of human b7-h2 protein
03/20/2003WO2002053728A3 Gene disruption methodologies for drug target discovery
03/20/2003WO2002050098A3 Haplotypes of the prlr gene
03/20/2003WO2002046417A3 Adipocyte complement related protein zacrp3x2
03/20/2003WO2002038726A3 Paramyxovirus vector for gene transfer to the cardiovascular system
03/20/2003WO2002034882A3 Genes regulating programmed cell death
03/20/2003WO2002033103A3 Non-human mammal with modified pacap type i receptor
03/20/2003WO2002029051A3 Human secretin receptor-like gpcr
03/20/2003WO2002028408A3 Compositions and methods for the transport of biologically active agents across cellular barriers
03/20/2003WO2002026961A3 Production process of surfactin
03/20/2003WO2002022809A9 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
03/20/2003WO2002022673A3 Proteins participating in nucleotide metabolism and genes coding for the same from ashbya gossypii
03/20/2003WO2002022667A9 Twin-arginine translocation in bacillus
03/20/2003WO2002020748A3 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof
03/20/2003WO2002020718A9 Osteoclast-associated receptor
03/20/2003WO2002020032A9 Stat3 agonists and antagonists and therapeutic uses thereof
03/20/2003WO2002018620A3 Neutrokine-alpha and neutrokine-alpha splice variant
03/20/2003WO2002018445A9 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
03/20/2003WO2002018423A9 Bioactive peptide for cell adhesion
03/20/2003WO2002017947A3 Use of t proteins for the differential characterization and treatment of lesions and tumors of the nervous system
03/20/2003WO2002009641A9 Promyostatin peptides and methods of using same
03/20/2003WO2002008280B1 SCREENING METHODS BASED ON SUPERACTIVATED αVβ3 INTEGRIN
03/20/2003WO2002008260A9 Bstp-ecg1 protein and related reagents and methods of use thereof
03/20/2003WO2002006312A3 Disease-associated gene
03/20/2003WO2002004520A3 Transporters and ion channels
03/20/2003WO2002004490A3 Lipid metabolism molecules
03/20/2003WO2001094386A3 Method for the extraction and the use of antibiotically effective peptides for treating infectious diseases
03/20/2003WO2001078894A3 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
03/20/2003WO2001074860A3 Methods of identifying integrin ligands using differential gene expression
03/20/2003WO2001070253A8 Use of mia in immunotherapy
03/20/2003US20030056249 Nucleotide sequences coding polypeptides for use in the generation of disease and stress resistant plants
03/20/2003US20030056247 Transcription factor for use in controlling flowering in plants
03/20/2003US20030056244 Feed additive compositions and methods
03/20/2003US20030056241 Chicken leukemia inhibitory factor (LIF) and gene thereof
03/20/2003US20030056240 Transgenic animal model for use in the treatment of diabetes
03/20/2003US20030056239 NMP35 apoptosis inhibitor gene disruptions, compositions and methods related thereto
03/20/2003US20030056238 GABA B1A receptor disruptions, compositions and methods relating thereto
03/20/2003US20030056236 Model
03/20/2003US20030056234 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of myocardial infarction, atherosclerosis and cardiovascular disorders
03/20/2003US20030056232 Animal showing schizophrenia-like abnormality in cognitive behaviors and method of constructing the same
03/20/2003US20030056231 Development of transgenic model for interventions in neurodegenerative diseases
03/20/2003US20030056229 Nucleotide sequences coding polypeptide for use in the treatment of leukemias, autoimmune and arthritic diseases
03/20/2003US20030055261 Compounds with growth hormone releasing properties
03/20/2003US20030055243 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis
03/20/2003US20030055239 Human receptor tyrosine kinase, KDR
03/20/2003US20030055238 Nucleotide sequences coding polypeptide for use in the treatment of schizophrenia, parkinson's, drug addiction and eating disorders
03/20/2003US20030055237 Isolated human secreted proteins, nucleic acid molecules encoding secreted proteins and uses thereof
03/20/2003US20030055236 Secreted protein HKABT24
03/20/2003US20030055234 Nucleotide sequences coding preferential polypeptide for use in the the treatment of atherosclerosis, hypertension, viral diseases, heart, skin and nervous system disorders
03/20/2003US20030055232 Nucleotide sequences coding enzymatic polypeptide for use in the generation of lysine
03/20/2003US20030055231 Nucleotide sequences coding polypeptides for use in the treatment, prevention and diagnosis of osteoarthritis and cancer
03/20/2003US20030055222 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030055221 Flint polypeptide for use in the treatment of inflammatory disorders
03/20/2003US20030055220 Protein complex for use in the diagnosis and prevention of bacterial infections
03/20/2003US20030055218 Human receptor proteins; related reagents and methods
03/20/2003US20030055217 Peptides derived from STEAP1
03/20/2003US20030055216 Nucleotide sequences coding polypeptide for use in the treatment of tumors
03/20/2003US20030055215 Calcium-binding protein for use in the treatment of inflammation, tumors and skin disorders
03/20/2003US20030055213 Peptide for use in the treatment of hypertension, asthma, cerebral disorders, angina pectoris, kidney and heart disorders
03/20/2003US20030055019 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
03/20/2003US20030055017 Gene therapy
03/20/2003US20030054997 OB protein compositions and methods
03/20/2003US20030054996 Contacting complex comprising a GRP94 protein with a binding agent that is immobilized to a solid phase support, to immobilize the complex to solid phase support; collecting the remaining sample; eluting the complex from solid phase support
03/20/2003US20030054994 Apoptosis inducing proteinaceous substance
03/20/2003US20030054991 Inhibitors of glycosaminoglycans
03/20/2003US20030054989 For diagnosis, treatment, and/or prevention of various diseases and/or disorders
03/20/2003US20030054987 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054986 Novel DNA and to the recombinant production of novel polypeptides encoded by that DNA
03/20/2003US20030054554 Albumin derivatives with therapeutic functions
03/20/2003US20030054550 Cardiac hypertrophy factor and uses therefor
03/20/2003US20030054548 Lentiviral packaging constructs
03/20/2003US20030054533 Novel expansin polynucleotides, related polypeptides and methods of use
03/20/2003US20030054522 Nucleotide sequences for use as gene transfer tools in plants
03/20/2003US20030054517 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054516 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 ... 2916